{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:40:27Z","timestamp":1787244027569,"version":"build-2736575974"},"reference-count":68,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,20]],"date-time":"2024-09-20T00:00:00Z","timestamp":1726790400000},"content-version":"vor","delay-in-days":385,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Prevention of Alzheimer's Disease"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.14283\/jpad.2023.52","type":"journal-article","created":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T04:21:05Z","timestamp":1682655665000},"page":"381-386","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Adding the Topographical Information from Tau-PET to the A\/T\/(N) Framework: Steps Towards Staging AD in Vivo"],"prefix":"10.1016","volume":"10","author":[{"given":"J.","family":"Therriault","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Gauthier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Rosa-Neto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.14283\/jpad.2023.52_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jalz.2011.10.007","article-title":"National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease","volume":"8","author":"Hyman","year":"2012","journal-title":"Alzheimer's Dement"},{"issue":"1","key":"10.14283\/jpad.2023.52_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00401-011-0910-3","article-title":"National institute on aging-Alzheimer's association guidelines for the neuropathologic assessment of Alzheimer's disease: A practical approach","volume":"123","author":"Montine","year":"2012","journal-title":"Acta Neuropathol"},{"issue":"7","key":"10.14283\/jpad.2023.52_bib3","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer's disease","volume":"34","author":"McKhann","year":"1984","journal-title":"Neurology"},{"issue":"5","key":"10.14283\/jpad.2023.52_bib4","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1093\/brain\/aww027","article-title":"Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's disease","volume":"139","author":"Ossenkoppele","year":"2016","journal-title":"Brain"},{"issue":"4","key":"10.14283\/jpad.2023.52_bib5","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s00401-019-02036-6","article-title":"Alzheimer's disease clinical variants show distinct regional patterns of neurofibrillary tangle accumulation [Internet]","volume":"138","author":"Petersen","year":"2019","journal-title":"Acta Neuropathol"},{"key":"10.14283\/jpad.2023.52_bib6","first-page":"1","article-title":"Progressive dysexecutive syndrome due to Alzheimer's disease: a description of 55 cases and comparison to other phenotypes","author":"Townley","year":"2020","journal-title":"Brain Commun"},{"issue":"1","key":"10.14283\/jpad.2023.52_bib7","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1001\/jamaneurol.2021.4417","article-title":"Research Criteria for the Behavioral Variant of Alzheimer Disease: A Systematic Review and Meta-analysis","volume":"79","author":"Ossenkoppele","year":"2022","journal-title":"JAMA Neurol"},{"issue":"S1","key":"10.14283\/jpad.2023.52_bib8","article-title":"Intrinsic connectivity of the human brain provides scaffold for tau aggregation in clinical variants of Alzheimer's disease","volume":"14","author":"Therriault","year":"2022","journal-title":"Sci. Transl. Med."},{"issue":"10","key":"10.14283\/jpad.2023.52_bib9","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1093\/brain\/awm213","article-title":"Focal cortical presentations of Alzheimer's disease","volume":"130","author":"Alladi","year":"2007","journal-title":"Brain"},{"issue":"July","key":"10.14283\/jpad.2023.52_bib10","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1212\/WNL.0000000000002923","article-title":"A\/T\/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers","volume":"87","author":"Jack","year":"2016","journal-title":"Neurology"},{"issue":"4","key":"10.14283\/jpad.2023.52_bib11","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease [Internet]","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimer's Dement"},{"issue":"2","key":"10.14283\/jpad.2023.52_bib12","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S1474-4422(12)70291-0","article-title":"Tracking pathophysiological processes in Alzheimer's disease: An updated hypothetical model of dynamic biomarkers","volume":"12","author":"Jack","year":"2013","journal-title":"Lancet Neurol"},{"issue":"9","key":"10.14283\/jpad.2023.52_bib13","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJMoa1202753","article-title":"Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease [Internet]","volume":"367","author":"Bateman","year":"2012","journal-title":"N. Engl. J. Med"},{"key":"10.14283\/jpad.2023.52_bib14","doi-asserted-by":"crossref","first-page":"104450","DOI":"10.1016\/j.ebiom.2023.104450","article-title":"Rates of regional tau accumulation in ageing and across the Alzheimer's disease continuum: an AIBL 18F-MK6240 PET study [Internet]","volume":"88","author":"Krishnadas","year":"2023","journal-title":"eBioMedicine"},{"issue":"4","key":"10.14283\/jpad.2023.52_bib15","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S1474-4422(13)70044-9","article-title":"Amyloid-\u03b2 deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: A prospective cohort study","volume":"12","author":"Villemagne","year":"2013","journal-title":"Lancet Neurol"},{"issue":"3","key":"10.14283\/jpad.2023.52_bib16","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.neuron.2014.10.038","article-title":"The evolution of preclinical Alzheimer's disease: Implications for prevention trials [Internet]","volume":"84","author":"Sperling","year":"2014","journal-title":"Neuron"},{"issue":"3","key":"10.14283\/jpad.2023.52_bib17","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jalz.2011.03.003","article-title":"Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"Sperling","year":"2011","journal-title":"Alzheimer's Dement"},{"key":"10.14283\/jpad.2023.52_bib18","unstructured":"Dubois B, Hampel H, Feldman HH, et al. Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria. 2016."},{"key":"10.14283\/jpad.2023.52_bib19","article-title":"Frequency of biologically-defined AD in relation to age, sex, APOE\u03b54 and cognitive impairment","author":"Therriault","year":"2021","journal-title":"Neurology"},{"issue":"4","key":"10.14283\/jpad.2023.52_bib20","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/NEN.0b013e31824b211b","article-title":"Accuracy of the clinical diagnosis of Alzheimer disease at National Institute on Aging Alzheimer Disease Centers, 2005\u20132010","volume":"71","author":"Beach","year":"2012","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.14283\/jpad.2023.52_bib21","first-page":"1","article-title":"Staging of Alzheimer's disease: past, present, and future perspectives [Internet]","author":"Therriault","year":"2022","journal-title":"Trends Mol. Med."},{"issue":"11","key":"10.14283\/jpad.2023.52_bib22","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1001\/jama.2018.12917","article-title":"Discriminative accuracy of [18F]flortaucipir positron emission tomography for Alzheimer disease vs other neurodegenerative disorders","volume":"320","author":"Ossenkoppele","year":"2018","journal-title":"JAMA - J. Am. Med. Assoc."},{"issue":"6","key":"10.14283\/jpad.2023.52_bib23","doi-asserted-by":"crossref","first-page":"20S","DOI":"10.2967\/jnumed.121.263196","article-title":"Tau PET Imaging in Neurodegenerative Disorders","volume":"63","author":"Groot","year":"2022","journal-title":"J. Nucl. Med."},{"issue":"12","key":"10.14283\/jpad.2023.52_bib24","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1136\/jnnp.2009.204008","article-title":"The ADAS-cog in Alzheimer's disease clinical trials: Psychometric evaluation of the sum and its parts","volume":"81","author":"Cano","year":"2010","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"6","key":"10.14283\/jpad.2023.52_bib25","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.jalz.2011.01.005","article-title":"Suitability of the Clinical Dementia Rating-Sum of Boxes as a single primary endpoint for Alzheimer's disease trials","volume":"7","author":"Coley","year":"2011","journal-title":"Alzheimer's Dement"},{"key":"10.14283\/jpad.2023.52_bib26","first-page":"1","article-title":"Assessment of Demographic, Genetic, and Imaging Variables Associated with Brain Resilience and Cognitive Resilience to Pathological Tau in Patients with Alzheimer Disease","author":"Ossenkoppele","year":"2020","journal-title":"JAMA Neurol"},{"issue":"1","key":"10.14283\/jpad.2023.52_bib27","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/ana.25246","article-title":"Combined neuropathological pathways account for age-related risk of dementia","volume":"84","author":"Power","year":"2018","journal-title":"Ann. Neurol."},{"issue":"24","key":"10.14283\/jpad.2023.52_bib28","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1212\/01.wnl.0000271090.28148.24","article-title":"Mixed brain pathologies account for most dementia cases in community-dwelling older persons","volume":"69","author":"Schneider","year":"2007","journal-title":"Neurology"},{"issue":"7","key":"10.14283\/jpad.2023.52_bib29","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1093\/brain\/awab099","article-title":"Comorbid neuropathological diagnoses in early versus late-onset Alzheimer's disease","volume":"144","author":"Spina","year":"2021","journal-title":"Brain"},{"issue":"14","key":"10.14283\/jpad.2023.52_bib30","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1002\/1873-3468.13108","article-title":"Tau filaments in neurodegenerative diseases","volume":"592","author":"Goedert","year":"2018","journal-title":"FEBS Lett"},{"key":"10.14283\/jpad.2023.52_bib31","article-title":"Biomarker modeling of Alzheimer's disease using PET-based Braak staging. Nat","author":"Therriault","year":"2022","journal-title":"Aging"},{"issue":"11","key":"10.14283\/jpad.2023.52_bib32","doi-asserted-by":"crossref","first-page":"3477","DOI":"10.1093\/brain\/awaa276","article-title":"18F-flortaucipir PET to autopsy comparisons in Alzheimer's disease and other neurodegenerative diseases","volume":"143","author":"Soleimani-Meigooni","year":"2020","journal-title":"Brain"},{"issue":"4","key":"10.14283\/jpad.2023.52_bib33","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1007\/s00259-020-05035-y","article-title":"Characterization of MK6240, a tau PET tracer, in autopsy brain tissue from Alzheimer's disease cases","volume":"48","author":"Malarte","year":"2021","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"issue":"3","key":"10.14283\/jpad.2023.52_bib34","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.jalz.2019.09.079","article-title":"Tau-positron emission tomography correlates with neuropathology findings","volume":"16","author":"Lowe","year":"2020","journal-title":"Alzheimer's Dement"},{"issue":"1","key":"10.14283\/jpad.2023.52_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40478-016-0315-6","article-title":"An autoradiographic evaluation of AV-1451 Tau PET in dementia [Internet]","volume":"4","author":"Lowe","year":"2016","journal-title":"Acta Neuropathol. Commun."},{"issue":"6","key":"10.14283\/jpad.2023.52_bib36","doi-asserted-by":"crossref","first-page":"830","DOI":"10.2967\/jnumed.121.263694","article-title":"Tau Beats Amyloid in Predicting Brain Atrophy in Alzheimer Disease: Implications for Prognosis and Clinical Trials","volume":"63","author":"Malpetti","year":"2022","journal-title":"J. Nucl. Med."},{"issue":"524","key":"10.14283\/jpad.2023.52_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1126\/scitranslmed.aau5732","article-title":"Prospective longitudinal atrophy in Alzheimer's disease correlates with the intensity and topography of baseline tau-PET. [Internet]","volume":"12","author":"La Joie","year":"2020","journal-title":"Sci. Transl. Med."},{"issue":"17","key":"10.14283\/jpad.2023.52_bib38","doi-asserted-by":"crossref","first-page":"6842","DOI":"10.18632\/aging.204293","article-title":"In vivo tau staging in Alzheimer's disease","volume":"14","author":"Therriault","year":"2022","journal-title":"Aging (Albany. NY)"},{"issue":"10","key":"10.14283\/jpad.2023.52_bib39","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1001\/jamaneurol.2019.1971","article-title":"Prevalence of Biologically vs Clinically Defined Alzheimer Spectrum Entities Using the National Institute on Aging-Alzheimer's Association Research Framework","volume":"76","author":"Jack","year":"2019","journal-title":"JAMA Neurol"},{"issue":"4","key":"10.14283\/jpad.2023.52_bib40","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00401-006-0127-z","article-title":"Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry","volume":"112","author":"Braak","year":"2006","journal-title":"Acta Neuropathol"},{"issue":"5","key":"10.14283\/jpad.2023.52_bib41","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.neuron.2016.01.028","article-title":"PET Imaging of Tau Deposition in the Aging Human Brain","volume":"89","author":"Sch\u00f6ll","year":"2016","journal-title":"Neuron"},{"issue":"1","key":"10.14283\/jpad.2023.52_bib42","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1093\/brain\/awx320","article-title":"Widespread brain tau and its association with ageing, Braak stage and Alzheimer's dementia","volume":"141","author":"Lowe","year":"2018","journal-title":"Brain"},{"issue":"9","key":"10.14283\/jpad.2023.52_bib43","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.1093\/brain\/awaa180","article-title":"18F-MK-6240 PET for early and late detection of neurofibrillary tangles","volume":"143","author":"Pascoal","year":"2020","journal-title":"Brain"},{"issue":"11","key":"10.14283\/jpad.2023.52_bib44","doi-asserted-by":"crossref","first-page":"3517","DOI":"10.1093\/brain\/awab248","article-title":"Longitudinal 18F-MK-6240 tau tangles accumulation follows Braak stages","volume":"144","author":"Pascoal","year":"2021","journal-title":"Brain"},{"issue":"5","key":"10.14283\/jpad.2023.52_bib45","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1093\/brain\/aww023","article-title":"Regional profiles of the candidate tau PET ligand 18F-AV-1451 recapitulate key features of Braak histopathological stages","volume":"139","author":"Schwarz","year":"2016","journal-title":"Brain"},{"key":"10.14283\/jpad.2023.52_bib46","first-page":"60","article-title":"Multicenter F-18-PI-2620 PET for in vivo Braak staging of tau pathology in Alzheimer's disease. 59","author":"Rullmann","year":"2021","journal-title":"Jahrestagung der Dtsch. Gesellschaft f\u00fcr Nukl"},{"issue":"11","key":"10.14283\/jpad.2023.52_bib47","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.2967\/jnumed.118.221697","article-title":"Progressive tau accumulation in Alzheimer disease: 2-year follow-up study","volume":"60","author":"Cho","year":"2019","journal-title":"J. Nucl. Med."},{"issue":"8","key":"10.14283\/jpad.2023.52_bib48","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1001\/jamaneurol.2020.0989","article-title":"Diagnostic performance of RO948 F 18 tau positron emission tomography in the differentiation of alzheimer disease from other neurodegenerative disorders","volume":"77","author":"Leuzy","year":"2020","journal-title":"JAMA Neurol"},{"issue":"2","key":"10.14283\/jpad.2023.52_bib49","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1001\/jamaneurol.2021.4654","article-title":"Biomarker-Based Prediction of Longitudinal Tau Positron Emission Tomography in Alzheimer Disease","volume":"79","author":"Leuzy","year":"2022","journal-title":"JAMA Neurol"},{"key":"10.14283\/jpad.2023.52_bib50","first-page":"1","article-title":"Divergent Cortical Tau Positron Emission Tomography Patterns Among Patients With Preclinical Alzheimer Disease","author":"Young","year":"2022","journal-title":"JAMA Neurol"},{"issue":"5","key":"10.14283\/jpad.2023.52_bib51","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1038\/s41591-021-01309-6","article-title":"Four distinct trajectories of tau deposition identified in Alzheimer's disease","volume":"27","author":"Vogel","year":"2021","journal-title":"Nat. Med."},{"issue":"1","key":"10.14283\/jpad.2023.52_bib52","first-page":"e81","article-title":"Topographical distribution of amyloid-\u03b2, tau and atrophy in behavioral\/dysexecutive AD patients","volume":"96","author":"Therriault","year":"2020","journal-title":"Neurology"},{"key":"10.14283\/jpad.2023.52_bib53","series-title":"The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more \u201cpersonalized\u201d approach to cancer staging. 8th Editon","author":"Amin","year":"2017"},{"issue":"12","key":"10.14283\/jpad.2023.52_bib54","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1001\/jamainternmed.2018.4710","article-title":"Evaluating Progression-Free Survival as a Surrogate Outcome for Health-Related Quality of Life in Oncology: A Systematic Review and Quantitative Analysis","volume":"178","author":"Kovic","year":"2018","journal-title":"JAMA Intern. Med."},{"issue":"6","key":"10.14283\/jpad.2023.52_bib55","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1002\/ana.21388","article-title":"Alzheimer and frontotemporal pathology in subsets of primary progressive aphasia","volume":"63","author":"Mesulam","year":"2008","journal-title":"Ann. Neurol."},{"key":"10.14283\/jpad.2023.52_bib56","doi-asserted-by":"crossref","DOI":"10.1038\/s41591-022-02049-x","article-title":"Amyloid and tau PET-positive cognitively unimpaired individuals are at high risk for future cognitive decline","author":"Ossenkoppele","year":"2022","journal-title":"Nat. Med."},{"issue":"8","key":"10.14283\/jpad.2023.52_bib57","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/S1474-4422(22)00168-5","article-title":"Tau biomarkers in Alzheimer's disease: towards implementation in clinical practice and trials [Internet]","volume":"21","author":"Ossenkoppele","year":"2022","journal-title":"Lancet Neurol"},{"issue":"9","key":"10.14283\/jpad.2023.52_bib58","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1002\/alz.12321","article-title":"Visualization of neurofibrillary tangle maturity in Alzheimer's disease: A clinicopathologic perspective for biomarker research","volume":"17","author":"Moloney","year":"2021","journal-title":"Alzheimer's Dement"},{"issue":"2","key":"10.14283\/jpad.2023.52_bib59","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.cell.2019.09.001","article-title":"Alzheimer Disease: An Update on Pathobiology and Treatment Strategies [Internet]","volume":"179","author":"Long","year":"2019","journal-title":"Cell"},{"issue":"1","key":"10.14283\/jpad.2023.52_bib60","doi-asserted-by":"crossref","first-page":"3230","DOI":"10.1093\/brain\/awz268","article-title":"The bivariate distribution of amyloid-\u03b2 and tau: relationship with established neurocognitive clinical syndromes","volume":"142","author":"Jack","year":"2019","journal-title":"Brain"},{"issue":"2","key":"10.14283\/jpad.2023.52_bib61","doi-asserted-by":"crossref","first-page":"166","DOI":"10.2967\/jnumed.119.235879","article-title":"The Spatial-Temporal Ordering of Amyloid Pathology and Opportunities for PET Imaging","volume":"61","author":"Fantoni","year":"2020","journal-title":"J. Nucl. Med."},{"issue":"11","key":"10.14283\/jpad.2023.52_bib62","doi-asserted-by":"crossref","first-page":"e1538","DOI":"10.1212\/WNL.0000000000010256","article-title":"Multitracer model for staging cortical amyloid deposition using PET imaging","volume":"95","author":"Collij","year":"2020","journal-title":"Neurology"},{"issue":"11","key":"10.14283\/jpad.2023.52_bib63","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1001\/jamaneurol.2019.2214","article-title":"Staging \u03b2-Amyloid Pathology with Amyloid Positron Emission Tomography","volume":"76","author":"Mattsson","year":"2019","journal-title":"JAMA Neurol"},{"issue":"10","key":"10.14283\/jpad.2023.52_bib64","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1212\/WNL.0b013e3182840bbe","article-title":"Brain \u03b2-amyloid load approaches a plateau","volume":"80","author":"Jack","year":"2013","journal-title":"Neurology"},{"key":"10.14283\/jpad.2023.52_bib65","article-title":"Amyloid-beta plaque accumulation with longitudinal [18F]AZD4694","author":"Therriault","year":"2023","journal-title":"Alzheimer's Dement. Diagnosis, Assess. Dis. Monit."},{"issue":"7","key":"10.14283\/jpad.2023.52_bib66","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1001\/jamainternmed.2019.0462","article-title":"Assessment of the Clinical Benefit of Cancer Drugs Receiving Accelerated Approval","volume":"179","author":"Gyawali","year":"2019","journal-title":"JAMA Intern. Med."},{"issue":"4","key":"10.14283\/jpad.2023.52_bib67","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.3233\/JAD-215558","article-title":"Visually Identified Tau 18F-MK6240 PET Patterns in Symptomatic Alzheimer's Disease","volume":"88","author":"Krishnadas","year":"2022","journal-title":"J. Alzheimer's Dis"},{"key":"10.14283\/jpad.2023.52_bib68","doi-asserted-by":"crossref","unstructured":"Shuping JL, Rowe CC, Johnson KA, et al. Development, initial validation, and application of a visual read method for [18 F] MK-6240 tau PET. 2023;(July 2022):1\u201314.","DOI":"10.1002\/trc2.12372"}],"container-title":["The Journal of Prevention of Alzheimer's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2274580724001973?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2274580724001973?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T19:06:16Z","timestamp":1736449576000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2274580724001973"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":68,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S2274580724001973"],"URL":"https:\/\/doi.org\/10.14283\/jpad.2023.52","relation":{},"ISSN":["2274-5807"],"issn-type":[{"value":"2274-5807","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adding the Topographical Information from Tau-PET to the A\/T\/(N) Framework: Steps Towards Staging AD in Vivo","name":"articletitle","label":"Article Title"},{"value":"The Journal of Prevention of Alzheimer's Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.14283\/jpad.2023.52","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2023 THE AUTHORS. Published by Elsevier Masson SAS on behalf of SERDI Publisher. Published by Elsevier Masson SAS","name":"copyright","label":"Copyright"}]}}